Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3447 results

Sort By:

Individualized Magnetic Stimulation for Post-stroke Cognitive Recovery: Optimization, Validation & Efficacy

Study ID: NCT07150169
Start Date: 2025-11-01
End Date: 2027-11-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

Active TMS disruption

Sham TMS disruption

Sponsor

Earth hint

Source: clinicaltrials.gov

Share:
Add to list

PLatform for Adaptive Trials In Perinatal UnitS - [Core Protocol]

Study ID: NCT06461429
Start Date: 2025-11-01
End Date: 2050-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100000

Intervention / Treatment

Erythromycin

Amoxicillin and Erythromycin

Azithromycin

Caffeine citrate 20 mg/kg load and 10 mg/kg daily maintenance.

Caffeine citrate 30 mg/kg load and 15 mg/kg daily maintenance.

Caffeine citrate 40 mg/kg load and 20 mg/kg daily maintenance

Sponsor

University of Melbourne

Source: clinicaltrials.gov

Share:
Add to list

Anifrolumab Pregnancy Study

Study ID: NCT07049653
Start Date: 2026-01-31
End Date: 2030-12-10
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

627

Intervention / Treatment
Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

A Study of GM-XANTHO in Pressure Ulcer Patients

Study ID: NCT05199077
Start Date: 2026-09-01
End Date: 2029-04-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

58

Intervention / Treatment

GM-Xantho

Sponsor

Xantho Biotechnology Co., LTD

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Cranial Flap Fixation With Montage Flowable Settable Bone Paste

Study ID: NCT07103330
Start Date: 2026-03
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Metallic fixation hardware

Cranial flap placement and fixation using only Montage Flowable Settable Bone Paste

Sponsor

Abyrx, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an Alterning Pattern to Patients With Metastatic or Locally Advanced Triple-negative Breast Cancer

Study ID: NCT07151586
Start Date: 2025-10
End Date: 2029-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

260

Intervention / Treatment

Sacituzumab Govitecan / Trastuzumab Deruxtecan

Sponsor

UNICANCER

Source: clinicaltrials.gov

Share:
Add to list

Comparison Between Digital Nerve Microanastomosis and Traction Neurectomy in Post-Digital Amputation Pain: A Prospective Study

Study ID: NCT07102654
Start Date: 2025-12-01
End Date: 2026-07-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment
Sponsor

University of Montreal Hospital Center (CHUM)

Source: clinicaltrials.gov

Share:
Add to list

Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and Consolidation

Study ID: NCT07130695
Start Date: 2025-10-31
End Date: 2029-10-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

15

Intervention / Treatment

Olutasidenib Investigational Agent Administration

Sponsor

Virginia Commonwealth University

Source: clinicaltrials.gov

Share:
Add to list

Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT

Study ID: NCT04520139
Start Date: 2025-12
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

102

Intervention / Treatment

N-Acetyl-Cysteine

Placebo

Sponsor

University of California, Irvine

Source: clinicaltrials.gov

Share:
Add to list

SBAT for Health Equity

Study ID: NCT05744869
Start Date: 2026-08-01
End Date: 2030-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

SBAT Implementation

Usual Care

Sponsor

University of Rochester

Source: clinicaltrials.gov

Share:
Add to list